CIMEX
Price
$27.41
Change
+$0.31 (+1.14%)
Updated
Jul 2 closing price
Net Assets
146.86B
IFACX
Price
$27.11
Change
+$0.31 (+1.16%)
Updated
Jul 2 closing price
Net Assets
146.86B
Interact to see
Advertisement

CIMEX vs IFACX

CIMEX vs IFACX Comparison Chart in %
View a ticker or compare two or three
VS
CIMEX vs. IFACX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Buy and IFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX (147B) and IFACX (147B) have equal amount of cash in the bank . CIMEX pays higher dividends than IFACX: CIMEX (3.26) vs IFACX (2.84). CIMEX was incepted earlier than IFACX: CIMEX (24 years) vs IFACX (25 years). IFACX (1.31) is less costly to investors than CIMEX (0.83). CIMEX (65.00) and IFACX (65.00) have comparable annual turnover. CIMEX (250) and IFACX (250) have matching initial minimum investment requirements. CIMEX annual gain was more profitable for investors over the last year : 6.63 vs. IFACX (6.07). CIMEX return over 5 years is better than : 25.03 vs. IFACX (19.58).
CIMEXIFACXCIMEX / IFACX
Total Expense Ratio0.831.3163%
Annual Report Gross Expense Ratio0.831.3163%
Fund Existence24 years25 years-
Gain YTD6.9836.766103%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets147B147B100%
Annual Yield % from dividends3.262.84115%
Returns for 1 year6.636.07109%
Returns for 3 years34.3232.31106%
Returns for 5 years25.0319.58128%
Returns for 10 years75.4050.90148%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRSRX32.930.43
+1.32%
Russell Inv Global Real Estate Secs R6
HFYCX15.550.14
+0.91%
Hartford Schroders Intl Multi-Cp Val C
NEFSX45.200.39
+0.87%
Natixis US Equity Opportunities A
TRIEX31.10N/A
N/A
Nuveen International Eq Idx Retire
SCETX9.31-0.09
-0.96%
Virtus Ceredex Small-Cap Value Eq I